Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up.

[1]  J. Herbert.  HYPOTHALAMIC PEPTIDES , 1975, The Lancet.

[2]  J. Wade,et al.  Hemoglobin concentration and prognosis in symptomatic obstructive cerebrovascular disease. , 1987, Stroke.

[3]  C. Forbes,et al.  RELATION OF ATRIAL FIBRILLATION AND HIGH HAEMATOCRIT TO MORTALITY IN ACUTE STROKE , 1983, The Lancet.

[4]  J H Wood,et al.  Hemorheology of the cerebral circulation in stroke. , 1985, Stroke.

[5]  D. Jacobs,et al.  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. , 1989, The New England journal of medicine.

[6]  Daniel L. McGee,et al.  Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. , 1983, American heart journal.

[7]  P. Elwood,et al.  Mortality and anaemia in women. , 1974, Lancet.

[8]  C. Forbes,et al.  PLATELET AGGREGATION, HAEMATOCRIT, AND FIBRINOGEN , 1985, The Lancet.

[9]  J. Dormandy,et al.  Prognostic Significance of Rheological and Biochemical Findings in Patients with Intermittent Claudication , 1973, British medical journal.

[10]  H. Tohgi,et al.  Importance of the Hematocrit as a Risk Factor in Cerebral Infarction , 1978, Stroke.

[11]  DianaN. J. Lockwood.  BLOOD DONATION AND RISK OF CARDIOVASCULAR DISEASE , 1981, The Lancet.

[12]  M. Fujishima,et al.  Hematocrit as a risk factor of cerebral infarction: long-term prospective population survey in a Japanese rural community. , 1986, Stroke.

[13]  T. Dawber,et al.  II. Coronary Heart Disease in the Framingham Study , 1957 .

[14]  T. Pearson,et al.  EFFECT OF HÆMATOCRIT ON CEREBRAL BLOOD-FLOW IN MAN , 1977, The Lancet.

[15]  Z. Tj,et al.  Hemorheologic studies of cerebrovascular diseases , 1983 .

[16]  H. Knizley,et al.  Iron deficiency anemia, papilledema, thrombocytosis, and transient hemiparesis. , 1972, Archives of internal medicine.

[17]  Lowe Gd,et al.  Blood rheology and thrombosis. , 1981 .

[18]  J. Dormandy,et al.  Clinical, Haemodynamic, Rheological, and Biochemical Findings in 126 Patients with Intermittent Claudication , 1973, British medical journal.

[19]  T. Dawber,et al.  Some methodologic problems in the long-term study of cardiovascular disease: Observations on the Framingham study , 1959 .

[20]  J. Whisnant,et al.  Anemia and Intermittent Focal Cerebral Arterial Insufficiency , 1960 .

[21]  J. Mann,et al.  Intermittent claudication--a preventable condition. , 1979, American heart journal.

[22]  P. Sorlie,et al.  Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health Program , 1981 .

[23]  P. Wolf,et al.  Hemoglobin and the risk of cerebral infarction: the Framingham Study. , 1972, Stroke.

[24]  R. Koehler,et al.  Effect of hematocrit on cerebral blood flow. , 1986, The American journal of physiology.

[25]  T. Pearson,et al.  VASCULAR OCCLUSIVE EPISODES AND VENOUS HÆMATOCRIT IN PRIMARY PROLIFERATIVE POLYCYTHÆMLX , 1978, The Lancet.

[26]  J. Dormandy,et al.  Effect of Clofibrate on Blood Viscosity in Intermittent Claudication , 1974, British medical journal.

[27]  A. Nicolaides,et al.  BLOOD VISCOSITY, RED-CELL FLEXIBILITY, HÆMATOCRIT, AND PLASMA-FIBRINOGEN IN PATIENTS WITH ANGINA , 1977, The Lancet.

[28]  G. Ewy,et al.  Markedly decreased coronary blood flow in secondary polycythemia. , 1992, American heart journal.

[29]  P. Burge,et al.  MORBIDITY AND MORTALITY IN PSEUDOPOLYCYTHÆMIA , 1975, The Lancet.

[30]  T. Li,et al.  [A randomized control trial of isovolemic hemodilution therapy in cor pulmonale]. , 1992, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao.

[31]  T. Khosla.  SUDDEN DEATH AND SPORT , 1975, The Lancet.

[32]  R B D'Agostino,et al.  Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. , 1988, Statistics in medicine.

[33]  L. Cohn.  Hematocrit and coronary heart disease. , 1984, American heart journal.

[34]  R. D'Agostino,et al.  Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. , 1987, American heart journal.

[35]  J. H. Lawrence,et al.  THE NATURE AND TREATMENT OF POLYCYTHEMIA STUDIES ON 263 PATIENTS , 1953, Medicine.

[36]  I Hutton,et al.  Relation between extent of coronary artery disease and blood viscosity. , 1980, British medical journal.

[37]  S. Pollock,et al.  HAEMATOCRIT AND PLATELET AGGREGATION , 1984, The Lancet.

[38]  Lond Mb.  Frederick Ronald Chistopher Casson. , 1975 .

[39]  D. Becker,et al.  Cerebral blood flow is regulated by changes in blood pressure and in blood viscosity alike. , 1986, Stroke.

[40]  R. D'Agostino,et al.  Fibrinogen and risk of cardiovascular disease. The Framingham Study. , 1987, JAMA.

[41]  J. Marshall,et al.  EFFECT OF HAEMATOCRIT ON CAROTID STENOSIS AND CEREBRAL INFARCTION , 1981, The Lancet.

[42]  V. Nguyen.  Fibrinogen and risk of cardiovascular disease: Kannel WB, Wolf PA, Castelli WP, et al JAMA 258: 1183–1186 Sep 1987 , 1988 .

[43]  R. Love.  Trusses for Femoral Hernia , 1966 .

[44]  R. D'Agostino,et al.  The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. , 1987, Circulation.